Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Drug of abuse testing industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Sample trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Drug of Abuse Testing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorable regulatory scenario in developed economies
3.3.1.2. Increasing usage of drug of abuse testing devices in law enforcement agencies
3.3.1.3. Growing number of clinical laboratories
3.3.1.4. Rising technological advancements
3.3.2. Industry pitfalls and challenges
3.3.2.1. Dearth of trained laboratory professionals
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By sample
3.4.3. By end-use
3.5. Porter’s analysis
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Drug of Abuse Testing Market, By Product
4.1. Key segment trends
4.2. Analyzers
4.2.1. Market size, by region, 2014 – 2025
4.2.2. Breath analyzers
4.2.2.1. Market size, by region, 2014 – 2025
4.2.3. Immunoassay analyzers
4.2.3.1. Market size, by region, 2014 – 2025
4.2.4. Chromatographic analyzers
4.2.4.1. Market size, by region, 2014 – 2025
4.3. Rapid testing devices
4.3.1. Market size, by region, 2014 – 2025
4.4. Consumables
4.4.1. Market size, by region, 2014 – 2025
Chapter 5. Drug of Abuse Testing Market, By Sample
5.1. Key segment trends
5.2. Urine
5.2.1. Market size, by region, 2014 – 2025
5.3. Saliva
5.3.1. Market size, by region, 2014 – 2025
5.4. Hair
5.4.1. Market size, by region, 2014 – 2025
5.5. Others
5.5.1. Market size, by region, 2014 – 2025
Chapter 6. Drug of Abuse Testing Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014 – 2025
6.3. Forensic laboratories
6.3.1. Market size, by region, 2014 – 2025
6.4. Diagnostic laboratories
6.4.1. Market size, by region, 2014 – 2025
6.5. Law enforcement agencies
6.5.1. Market size, by region, 2014 – 2025
Chapter 7. Drug of Abuse Testing Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country 2014 – 2025
7.2.2. Market size, by product, 2014 – 2025
7.2.2.1. Market size, by analyzers, 2014 – 2025
7.2.3. Market size, by sample, 2014 – 2025
7.2.4. Market size, by end-use, 2014 – 2025
7.2.5. U.S.
7.2.5.1. Market size, by product, 2014 – 2025
7.2.5.1.1. Market size, by analyzers, 2014 – 2025
7.2.5.2. Market size, by sample, 2014 – 2025
7.2.5.3. Market size, by end-use, 2014 – 2025
7.2.6. Canada
7.2.6.1. Market size, by product, 2014 – 2025
7.2.6.1.1. Market size, by analyzers, 2014 – 2025
7.2.6.2. Market size, by sample, 2014 – 2025
7.2.6.3. Market size, by end-use, 2014 – 2025
7.3. Europe
7.3.1. Market size, by country 2014 – 2025
7.3.2. Market size, by product, 2014 – 2025
7.3.2.1. Market size, by analyzers, 2014 – 2025
7.3.3. Market size, by sample, 2014 – 2025
7.3.4. Market size, by end-use, 2014 – 2025
7.3.5. Germany
7.3.5.1. Market size, by product, 2014 – 2025
7.3.5.1.1. Market size, by analyzers, 2014 – 2025
7.3.5.2. Market size, by sample, 2014 – 2025
7.3.5.3. Market size, by end-use, 2014 – 2025
7.3.6. UK
7.3.6.1. Market size, by product, 2014 – 2025
7.3.6.1.1. Market size, by analyzers, 2014 – 2025
7.3.6.2. Market size, by sample, 2014 – 2025
7.3.6.3. Market size, by end-use, 2014 – 2025
7.3.7. France
7.3.7.1. Market size, by product, 2014 – 2025
7.3.7.1.1. Market size, by analyzers, 2014 – 2025
7.3.7.2. Market size, by sample, 2014 – 2025
7.3.7.3. Market size, by end-use, 2014 – 2025
7.3.8. Italy
7.3.8.1. Market size, by product, 2014 – 2025
7.3.8.1.1. Market size, by analyzers, 2014 – 2025
7.3.8.2. Market size, by sample, 2014 – 2025
7.3.8.3. Market size, by end-use, 2014 – 2025
7.3.9. Spain
7.3.9.1. Market size, by product, 2014 – 2025
7.3.9.1.1. Market size, by analyzers, 2014 – 2025
7.3.9.2. Market size, by sample, 2014 – 2025
7.3.9.3. Market size, by end-use, 2014 – 2025
7.4. Asia Pacific
7.4.1. Market size, by country 2014 – 2025
7.4.2. Market size, by product, 2014 – 2025
7.4.2.1. Market size, by analyzers, 2014 – 2025
7.4.3. Market size, by sample, 2014 – 2025
7.4.4. Market size, by end-use, 2014 – 2025
7.4.5. Japan
7.4.5.1. Market size, by product, 2014 – 2025
7.4.5.1.1. Market size, by analyzers, 2014 – 2025
7.4.5.2. Market size, by sample, 2014 – 2025
7.4.5.3. Market size, by end-use, 2014 – 2025
7.4.6. China
7.4.6.1. Market size, by product, 2014 – 2025
7.4.6.1.1. Market size, by analyzers, 2014 – 2025
7.4.6.2. Market size, by sample, 2014 – 2025
7.4.6.3. Market size, by end-use, 2014 – 2025
7.4.7. India
7.4.7.1. Market size, by product, 2014 – 2025
7.4.7.1.1. Market size, by analyzers, 2014 – 2025
7.4.7.2. Market size, by sample, 2014 – 2025
7.4.7.3. Market size, by end-use, 2014 – 2025
7.4.8. Australia
7.4.8.1. Market size, by product, 2014 – 2025
7.4.8.1.1. Market size, by analyzers, 2014 – 2025
7.4.8.2. Market size, by sample, 2014 – 2025
7.4.8.3. Market size, by end-use, 2014 – 2025
7.5. Latin America
7.5.1. Market size, by country 2014 – 2025
7.5.2. Market size, by product, 2014 – 2025
7.5.2.1. Market size, by analyzers, 2014 – 2025
7.5.3. Market size, by sample, 2014 – 2025
7.5.4. Market size, by end-use, 2014 – 2025
7.5.5. Brazil
7.5.5.1. Market size, by product, 2014 – 2025
7.5.5.1.1. Market size, by analyzers, 2014 – 2025
7.5.5.2. Market size, by sample, 2014 – 2025
7.5.5.3. Market size, by end-use, 2014 – 2025
7.5.6. Mexico
7.5.6.1. Market size, by product, 2014 – 2025
7.5.6.1.1. Market size, by analyzers, 2014 – 2025
7.5.6.2. Market size, by sample, 2014 – 2025
7.5.6.3. Market size, by end-use, 2014 – 2025
7.6. MEA
7.6.1. Market size, by country 2014 – 2025
7.6.2. Market size, by product, 2014 – 2025
7.6.2.1. Market size, by analyzers, 2014 – 2025
7.6.3. Market size, by sample, 2014 – 2025
7.6.4. Market size, by end-use, 2014 – 2025
7.6.5. South Africa
7.6.5.1. Market size, by product, 2014 – 2025
7.6.5.1.1. Market size, by analyzers, 2014 – 2025
7.6.5.2. Market size, by sample, 2014 – 2025
7.6.5.3. Market size, by end-use, 2014 – 2025
7.6.6. GCC Countries
7.6.6.1. Market size, by product, 2014 – 2025
7.6.6.1.1. Market size, by analyzers, 2014 – 2025
7.6.6.2. Market size, by sample, 2014 – 2025
7.6.6.3. Market size, by end-use, 2014 – 2025
Chapter 8. Company Profiles
8.1. ALERE (Abbott )
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Danaher ( Beckman Coulter, Inc.)
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Drägerwerk AG & Co. KGaA
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. F. Hoffmann-La Roche Ltd
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. LabCorp of America Holdings
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Quest Diagnostics Incorporated
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Randox Testing Services
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Siemens Healthcare Private Limited
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Thermo Fisher Scientific
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. United States Drug Testing Laboratories, Inc.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
